<< Back to News

System Formulary Update
Caplacizumab-yhdp (Cablivi)

Situation

Caplacizumab (Cablivi) 11 mg for injection was approved for addition to the health system formulary at the February 2021 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was reviewed: Caplacizumab 11 mg for injection

 Assessment/Recommendation

Change effective: Tuesday, April 6, 2021

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Caplacizumab 11 mg for injection

Note: Stock of this formulary product may vary at individual entities